AMPHASTAR PHARMACEUTICALS INC. - COMMON STOCK
31.02
14-February-25 15:45:00
15 minutes delayed
Stocks
-0.72
-2.27%
Today's range
30.95 - 31.90
ISIN
N/A
Source
NASDAQ
-
07 May 2021 15:05:00 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021
06 May 2021 15:05:02 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection
03 May 2021 05:00:00 By Nasdaq GlobeNewswire
-
29 Apr 2021 05:00:00 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
06 Apr 2021 15:05:00 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection
29 Mar 2021 05:00:00 By Nasdaq GlobeNewswire
-
15 Mar 2021 15:05:01 By Nasdaq GlobeNewswire
-
08 Mar 2021 16:39:05 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
26 Feb 2021 05:01:00 By Nasdaq GlobeNewswire